Żmudka, K.; Gałeczka-Turkiewicz, A.; Wroniecka, A.; Włosowicz, A.; Sobala-Szczygieł, B.; Mrochem-Kwarciak, J.; Czuba, Z.P.; Jaroszewicz, J.
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome. J. Clin. Med. 2024, 13, 1851.
https://doi.org/10.3390/jcm13071851
AMA Style
Żmudka K, Gałeczka-Turkiewicz A, Wroniecka A, Włosowicz A, Sobala-Szczygieł B, Mrochem-Kwarciak J, Czuba ZP, Jaroszewicz J.
Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome. Journal of Clinical Medicine. 2024; 13(7):1851.
https://doi.org/10.3390/jcm13071851
Chicago/Turabian Style
Żmudka, Karol, Alicja Gałeczka-Turkiewicz, Aleksandra Wroniecka, Aleksandra Włosowicz, Barbara Sobala-Szczygieł, Jolanta Mrochem-Kwarciak, Zenon P. Czuba, and Jerzy Jaroszewicz.
2024. "Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome" Journal of Clinical Medicine 13, no. 7: 1851.
https://doi.org/10.3390/jcm13071851
APA Style
Żmudka, K., Gałeczka-Turkiewicz, A., Wroniecka, A., Włosowicz, A., Sobala-Szczygieł, B., Mrochem-Kwarciak, J., Czuba, Z. P., & Jaroszewicz, J.
(2024). Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Post-Acute COVID-19 Syndrome. Journal of Clinical Medicine, 13(7), 1851.
https://doi.org/10.3390/jcm13071851